Acute pancreatitis.

Area of Science:

• Gastroenterology and Hepatology
• Immunology
• Critical Care Medicine

Background:

• Acute pancreatitis initiates as pancreatic injury, potentially triggering a systemic inflammatory response.
• This inflammatory cascade, driven by factors like alcohol and gallstones, involves intra-acinar zymogen activation and mediator release.
• The systemic inflammatory response is a key factor in distant organ failure and mortality associated with acute pancreatitis.

Purpose of the Study:

• To review the pathogenesis and clinical aspects of acute pancreatitis.
• To differentiate between findings in experimental models and human clinical pancreatitis.
• To highlight the limitations of current therapeutic strategies targeting inflammatory mediators.

Main Methods:

• Review of experimental models of acute pancreatitis.
• Analysis of clinical data and syndromes in human acute pancreatitis.
• Examination of the role of cytokines and proinflammatory mediators in disease progression.

Main Results:

• Experimental models have elucidated pancreatitis pathogenesis but do not fully replicate the human condition.
• Therapeutic attempts to block specific inflammatory mediators have yielded limited success in attenuating pancreatitis severity.
• The release of proinflammatory mediators is critical in driving systemic inflammation and organ failure.

Conclusions:

• Understanding the distinction between experimental and clinical acute pancreatitis is crucial for therapeutic development.
• Current strategies targeting single inflammatory mediators are insufficient for effective acute pancreatitis treatment.
• Further research is needed to develop more successful therapies for acute pancreatitis and prevent multiorgan failure.